Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Agitation in Patients With Dementia of the Alzheimer's Type”

35 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 35 results

Large-scale testing (Phase 3)Study completedNCT03226522
What this trial is testing

Addressing Dementia Via Agitation-Centered Evaluation

Who this might be right for
Agitation in Patients With Dementia of the Alzheimer's TypeAlzheimer DiseaseAgitation,Psychomotor
Axsome Therapeutics, Inc. 366
Large-scale testing (Phase 3)Ended earlyNCT04408755
What this trial is testing

Assessment of the Efficacy, Safety, and Tolerability of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type

Who this might be right for
Agitation in Patients With Dementia of the Alzheimer's Type
Otsuka Pharmaceutical Development & Commercialization, Inc. 184
Large-scale testing (Phase 3)Study completedNCT03031184
What this trial is testing

Study of Mirtazapine for Agitation in Dementia

Who this might be right for
Dementia
University of Sussex 207
Post-approval studies (Phase 4)Study completedNCT00260624
What this trial is testing

Escitalopram Treatment of Patients With Agitated Dementia

Who this might be right for
Alzheimer's DiseasePsychomotor Agitation
University of Rochester 20
Testing effectiveness (Phase 2)Study completedNCT02471196
What this trial is testing

Efficacy of ORM-12741 on Agitation/Aggression Symptoms in Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Orion Corporation, Orion Pharma 308
Large-scale testing (Phase 3)Study completedNCT00095719
What this trial is testing

Intramuscular Aripiprazole in Acutely Agitated Patients Diagnosed With Dementia

Who this might be right for
DementiaAlzheimer's Disease
Otsuka Pharmaceutical Development & Commercialization, Inc. 125
Testing effectiveness (Phase 2)Study completedNCT00012857
What this trial is testing

Pain Management and Behavioral Outcomes in Patients With Dementia

Who this might be right for
DementiaAlzheimer Disease, PainBehavior, Agitation
US Department of Veterans Affairs 66
Not applicableUnknownNCT00703430
What this trial is testing

Memantine on Aggression and Agitation of Alzheimer's Disease (AD)

Who this might be right for
Alzheimer's Disease
Peking University 50
Testing effectiveness (Phase 2)Study completedNCT00843518
What this trial is testing

Treatment for Aggression and Agitation in Patients With Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Eli Lilly and Company 132
Testing effectiveness (Phase 2)Ended earlyNCT01766336
What this trial is testing

A 36-Week Safety Extension Study of ELND005 as a Treatment for Agitation and Aggression in Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
OPKO Health, Inc. 296
Not applicableStudy completedNCT02686190
What this trial is testing

Effects of Light-therapy in Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Assistance Publique - Hôpitaux de Paris 91
Large-scale testing (Phase 3)Ended earlyNCT02817906
What this trial is testing

ITI-007 for the Treatment of Agitation in Patients With Dementia, Including Alzheimer's Disease

Who this might be right for
Agitation in Dementia, Including Alzheimer's Disease
Intra-Cellular Therapies, Inc. 177
Large-scale testing (Phase 3)Ended earlyNCT06736509
What this trial is testing

An Open-Label Study to Assess the Long-term Safety of AXS-05 in Subjects With Dementia of the Alzheimer's Type, ADVANCE-2 and ACCORD-2 Extension Study

Who this might be right for
Agitation in Patients With Dementia of the Alzheimer's TypeAlzheimer DiseaseAgitation, Psychomotor
Axsome Therapeutics, Inc. 139
Testing effectiveness (Phase 2)UnknownNCT04436081
What this trial is testing

Effects of THC-Free CBD Oil on Agitation in Patients With Alzheimer's Disease

Who this might be right for
Alzheimer DiseaseDementiaMajor Neurocognitive Disorder With Aggressive Behavior
Eastern Virginia Medical School 40
Large-scale testing (Phase 3)Study completedNCT02442765
What this trial is testing

Efficacy, Safety and Tolerability of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type

Who this might be right for
Agitation in Patients With Dementia of the Alzheimer's Type
Otsuka Pharmaceutical Development & Commercialization, Inc. 387
Testing effectiveness (Phase 2)Ended earlyNCT03044249
What this trial is testing

MP-101 in Dementia-Related Psychosis and/or Agitation and Aggression

Who this might be right for
PsychosisDementiaAggression+2 more
Mediti Pharma Inc. 81
Testing effectiveness (Phase 2)Looking for participantsNCT06803823
What this trial is testing

ONO-2020 in Patients With Agitation Associated With Alzheimer's Disease Dementia

Who this might be right for
Agitation Associated With Alzheimer's Disease Dementia
Ono Pharmaceutical Co. Ltd 90
Large-scale testing (Phase 3)Study completedNCT02442778
What this trial is testing

Efficacy, Safety, and Tolerability of AVP-786 for the Treatment of Agitation in Participants With Dementia of the Alzheimer's Type

Who this might be right for
Agitation in Participants With Dementia of the Alzheimer's Type
Otsuka Pharmaceutical Development & Commercialization, Inc. 522
Large-scale testing (Phase 3)Ended earlyNCT02446132
What this trial is testing

Long Term, Extension Study of the Safety and Efficacy of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type

Who this might be right for
Agitation in Patients With Dementia of the Alzheimer's Type
Otsuka Pharmaceutical Development & Commercialization, Inc. 1,197
Large-scale testing (Phase 3)Study completedNCT05557409
What this trial is testing

Assess the Efficacy and Safety of AXS-05 in Subjects With Alzheimer's Disease Agitation

Who this might be right for
Agitation in Patients With Dementia of the Alzheimer's TypeAlzheimer DiseaseAgitation
Axsome Therapeutics, Inc. 408
Load More Results